Strategic agreement integrates Optellum’s AI-powered lung nodule analysis with Volpara’s early cancer detection tools, enabling a more comprehensive approach to patient risk evaluation....
Single-use sleeve offers enhanced protection against contamination while improving efficiency for healthcare professionals....
The acquisition adds the ultrasound-based TIVUS™ system to Boston Scientific’s interventional portfolio, enhancing treatment options for hypertension and expanding its presence in renal denervation therapy. ...
The acquisition strengthens NAMSA’s leadership in medical device biological safety testing, adding expertise, lab capacity, and scientific resources to support global manufacturers....
Designed for fast-paced healthcare environments, the Sync Badge enables voice-activated, hands-free collaboration, urgent alerts, and real-time integration with connected medical systems, enhancing efficiency and patient care....
The innovative Care Delivery Platform (CDP) will integrate networked medical devices and telemedicine to provide hospital-level care to rural communities, enhancing healthcare accessibility and sustainability across the U.S....
Designed for physician office labs and stat labs, the compact XQ-320™ delivers rapid results in under 60 seconds with enhanced diagnostic capabilities, minimal maintenance, and the industry-first BeyondCare℠ Quality Monitor. ...
Pioneering Extravascular Renal Denervation for Resistant Hypertension ...
Early glaucoma detection, SightScore™ empowers eye care professionals with advanced genetic insights to identify high-risk individuals before symptoms appear, paving the way for proactive vision care....
Offering a long-acting, non-hormonal birth control option, the approval marks a significant milestone in expanding contraceptive choices for individuals seeking hormone-free alternatives. ...
